The Benton Visual Form Discrimination Test as a Predictor of Neurocognitive Disorder in Older Veterans
Archives of Clinical Neuropsychology · 2023
DOI: 10.1093/arclin/acac067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Clinical Neuropsychology, 2023. Verfasst von Brian A Maruyama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Kaiser Permanente Redwood City, Integrated Behavioral Health Services-Mental Health, Redwood City, CA, USA. Hauptthemen laut MEDLINE: Veterans, Dementia, Cognitive Dysfunction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Objective
The Benton Visual Form Discrimination Test (VFDT) is a commonly used measure of visual discrimination and visual recognition memory and has shown promise in distinguishing between different levels of cognitive impairment. We assess the predictive diagnostic utility of the VFDT in a sample of older Veterans with cognitive concerns.
Method
Subjects included a total of 172 mostly male Veterans over the age of 64 (mean = 76.0; SD = 7.6) recruited from a VA clinic specializing in neuropsychological assessment of older Veterans. The clinical sample included 56 subjects diagnosed with Major Neurocognitive Disorder, 74 diagnosed with Mild Neurocognitive Disorder, and 42 with No Neurocognitive Impairment. Impairment categories were modeled in separate multinomial logistic regressions with two versions of the VFDT as predictors: the Visual Form Discrimination Test-Recognition Subtest (VFDT-Rec) test (visual recognition memory) and the Visual Form Discrimination Test-Matching Subtest VFDT-Mat test (visual form discrimination). Years of education were included as a covariate.
Results
After adjusting for education, higher VFDT-Rec total scores were associated with lower odds of being categorized with a greater degree of cognitive/functional impairment (OR 0.66–0.83, p < .001). VFDT-Mat scores showed a similar pattern, but only reached statistical significance for the Major versus No Neurocognitive Impairment (OR = 0.77, p = .0010) and Major versus Mild comparisons (OR = 0.89, p = .0233).
Conclusions
The VFDT may enhance the confidence of differential diagnosis of dementia in older adult Veterans. Formal education-adjusted norms need to be established for clinical use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Kaiser Permanente Redwood City, Integrated Behavioral Health Services-Mental Health, Redwood City, CA, USA.
- Department of Veterans Affairs, VA Palo Alto Health Care System, Palo Alto, CA, USA.
- Department of Health Psychology, University of Missouri, Columbia, MO, USA.
- Department of Psychology, University of Alabama, Tuscaloosa, AL, USA.
- Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA.
ORCID-Profile: Brian A Maruyama, Julie Gretler
Förderung
- NIA NIH HHS
- National Institutes of Health
Zitieren
APA
Maruyama, B. A., Alipio Jocson, V. Z., Gretler, J., Doudell, K., Lazzeroni, L. C., Hernandez, B., Noda, A., Yesavage, J. A., & Kinoshita, L. M. (2023). The Benton Visual Form Discrimination Test as a Predictor of Neurocognitive Disorder in Older Veterans. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acac067
Vancouver
Maruyama BA, Alipio Jocson VZ, Gretler J, Doudell K, Lazzeroni LC, Hernandez B, et al. The Benton Visual Form Discrimination Test as a Predictor of Neurocognitive Disorder in Older Veterans. Archives of Clinical Neuropsychology. 2023. doi:10.1093/arclin/acac067
BibTeX
@article{Maruyama2023,
author = {Maruyama, Brian A and Alipio Jocson, Valerie Z and Gretler, Julie and Doudell, Kelly and Lazzeroni, Laura C and Hernandez, Beatriz and Noda, Art and Yesavage, Jerome A and Kinoshita, Lisa M},
title = {The Benton Visual Form Discrimination Test as a Predictor of Neurocognitive Disorder in Older Veterans},
journal = {Archives of Clinical Neuropsychology},
year = {2023},
doi = {10.1093/arclin/acac067}
}
EUVIMED